会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Long acting injectable formulations
    • 长效注射制剂
    • US08362086B2
    • 2013-01-29
    • US11207980
    • 2005-08-19
    • Mark D. SollPeter HansonKrishan KumarMonica Tejwani-Motwani
    • Mark D. SollPeter HansonKrishan KumarMonica Tejwani-Motwani
    • A61K31/63A61K31/7048
    • A61K31/00A61K9/0019A61K47/10A61K47/14A61K47/34A61K48/00
    • The application relates to long acting injectable (LAI) formulations for combating ectoparasites and endoparasites in mammals. In particular, this invention provides for a LAI formulation comprising a subcutaneously volatile solvent, a biologically acceptable polymer, a bioactive agents and optionally one or more anti-ectoparasitically or anti-endoparasitically acceptable additive or excipient. Surprisingly, the liquid long acting injectable formulations of the invention solve the problems associates with previous injectable formulations by having long term stability, being able to accommodate smaller needle diameters and achieving long acting effects in the control of pests in a mammal. The unique formulations of the invention also allow for combating ectoparasites and endoparasites which have become resistant to macrolide antibiotics.
    • 本申请涉及用于对抗哺乳动物体内寄生虫和内寄生虫的长效注射剂(LAI)制剂。 特别地,本发明提供了包含皮下挥发性溶剂,生物学上可接受的聚合物,生物活性剂和任选的一种或多种抗外寄生物或抗内分泌上可接受的添加剂或赋形剂的LAI制剂。 令人惊奇的是,本发明的液体长效注射制剂通过具有长期稳定性能够解决与先前可注射制剂相关的问题,能够适应较小的针头直径并且实现控制哺乳动物中害虫的长效应。 本发明的独特配方还允许抵抗已经变得对大环内酯类抗生素具有抗性的外寄生物和内寄生虫。
    • 3. 发明申请
    • Long acting injectable formulations
    • 长效注射制剂
    • US20070042013A1
    • 2007-02-22
    • US11207980
    • 2005-08-19
    • Mark SollPeter HansonKrishan KumarMonica Tejwani-Motwani
    • Mark SollPeter HansonKrishan KumarMonica Tejwani-Motwani
    • A01N43/04A01N25/00
    • A61K31/00A61K9/0019A61K47/10A61K47/14A61K47/34A61K48/00
    • The application relates to long acting injectable (LAI) formulations for combating ectoparasites and endoparasites in mammals. In particular, this invention provides for a LAI formulation comprising a subcutaneously volatile solvent, a biologically acceptable polymer, a bioactive agents and optionally one or more anti-ectoparasitically or anti-endoparasitically acceptable additive or excipient. Surprisingly, the liquid long acting injectable formulations of the invention solve the problems associates with previous injectable formulations by having long term stability, being able to accommodate smaller needle diameters and achieving long acting effects in the control of pests in a mammal. The unique formulations of the invention also allow for combating ectoparasites and endoparasites which have become resistant to macrolide antibiotics.
    • 本申请涉及用于对抗哺乳动物体内寄生虫和内寄生虫的长效注射剂(LAI)制剂。 特别地,本发明提供了包含皮下挥发性溶剂,生物学上可接受的聚合物,生物活性剂和任选的一种或多种抗外寄生物或抗内分泌上可接受的添加剂或赋形剂的LAI制剂。 令人惊奇的是,本发明的液体长效注射制剂通过具有长期稳定性能够解决与先前可注射制剂相关的问题,能够适应较小的针头直径并且实现控制哺乳动物中害虫的长效应。 本发明的独特配方还允许抵抗已经变得对大环内酯类抗生素具有抗性的外寄生物和内寄生虫。